Beta-amyloid precursor protein cleavage enzyme-1 expression in adult rat retinal neurons in the early period after lead exposure

Neural Regeneration Research

Volumn 6, Issue 14, 2011, Pages 1045-1051

  Huang, Jufang ^a   Huang, Kai ^a,b   Shang, Lei ^a   Wang, Hui ^a   Yan, Xiaoxin ^a   Xiong, Kun ^a  

^a Central South University   (China)

^b Shaoyang Medical College   (China)

Author keywords

Adult; Lead exposure; Neural regeneration; Retina; Sprague dawley rats; amyloid; amyloid precursor protein cleavage enzyme 1

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA AMYLOID PRECURSOR PROTEIN CLEAVAGE ENZYME 1; LEAD ACETATE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; MALE; MICROGLIA; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; RETINA NERVE CELL; UPREGULATION;

EID: 79960729002     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.14.001     Document Type: Article

References (38)

1. Pizzol M, Thomsen M, Andersen MS. Long-term human exposure to lead from different media and intake pathways. Sci Total Environ. 2010;408(22):5478-5488.
2. Schwartz BS, Stewart W F. Lead and cognitive function in adults: a questions and answers approach to a review of the evidence for cause, treatment, and prevention. Int Rev Psychiatry. 2007;19(6): 671-692.
3. Basha R, Reddy GR. Developmental exposure to lead and late life abnormalities of nervous system. Indian J Exp Biol. 2010; 48(7):636-641.
4. Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med. 2009;46(9):1241-1249.
5. Stewart W F, Schwartz BS. Effects of lead on the adult brain: a 15-year exploration. Am J Ind Med. 2007;50(10):729-739.
6. Migliore L, Coppedè F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res. 2009;667(1-2):82-97.
7. Yun SW, Hoyer S. Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer's disease? J Neural Transm. 2000;107(3): 355-368.
8. Blennow K, De Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368(9533):387-403.
9. Tomiyama T. Involvement of beta-amyloid in the etiology of Alzheimer's disease. Brain Nerve. 2010;62(7):691-699.
10. Basha MR, Murali M, Siddiqi HK, et al. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB J. 2005;19(14):2083-2084.
11. Cole SL, Vassar R. The basic biology of BACE1: a key therapeutic target for Alzheimer's disease. Curr Genomics. 2007;8(8): 509-530.
12. Oliveira LT, Louzada PR, de Mello FG, et al. Amyloid-β decreases nitric oxide production in cultured retinal neurons: a possible mechanism for synaptic dysfunction in Alzheimer's disease? Neurochem Res. 2011;36(1):163-169.
13. Greenberg BM, Frohman E. Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord. 2010; 3(3):153-160.
14. Xiong K, Clough RW, Struble RG, et al. Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE-1) proteins and activity in vivo in the rat retina. Exp Brain Res. 2007; 181(3):435-446.
15. Zhao J, Fu YF, Yasvoina M, et al. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: Implications for Alzheimer's disease pathogenesis. J Neurosci. 2007;27(14):3639-3649.
16. Chen D, Wang H, Tong JB, et al. Expression of synaptophysin in rat retina following acute high intraocular pressure. Acta Academiae Medicinae Militaris Tertiae. 2008;30(11):1040-1042.
17. Dowling JE. Retina. Shanghai: Shanghai Medical University Press. 1989.
18. Löffler KU, Edward DP, Tso MO. Immunoreactivity against tau,amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci. 1995;36(1):24-31.
19. Shimazawa M, Inokuchi Y, Okuno T, et al. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J Neurochem. 2008;107(1):279-290.
20. Guo L, Duggan J, Cordeiro MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res. 2010;7(1):3-14.
21. Lua Y, Lia Z, Zhang XQ, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography. Neurosci Letters. 2010;480(1):69-72.
22. Greenberg BM, Frohman E. Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord. 2010; 3(3):153-160.
23. Wei DL, Fu X, Jiang YM. Lead exposure and Alzheimer's disease. Gongye Weisheng yu Zhiyebing. 2006;32(6):379-382.
24. Prince M. Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer's disease? Epidemiology. 1998;9(6): 618-621.
25. Niklowitz WJ. Neurofibrillary changes after acute experimental lead poisoning. Neurology. 1975;25(10):927-934.
26. Niklowitz WJ, Mandybur TI. Neurofibrillary changes following childhood lead encephalopathy. J Neuropathol Exp Neurol. 1975;34(5):445-455.
27. Tohda M, Suwanakitch P, Jeenapongsa R, et al. Expression changes of the mRNA of Alzheimer's disease related factors in the permanent ischemic rat brain. Biol Pharm Bull. 2004;27(12): 2021-2023.
28. Uryu K, Chen XH, Martinex D, et al. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol. 2007;208(2):185-192.
29. Yan XX, Xiong K, Struble RG, et al. β-secretase expression in normal and functionally deprived rat olfactory bulbs: inverse correlation with oxidative metabolic activity. J Comp Neurol. 2007;501(1):52-69.
30. Xie ZC, Dong YL, Maeda U, et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid β-protein accumulation. J Neurosci. 2007;27(6):1247-1254.
31. Yang F, Li JS, Yang F. The effect of different lead acetate concentration on rat primary culture cortical neurons. Zhonghua Laodong Weisheng Zhiyebing Zazhi. 2004;22(3):217-218.
32. Neal A P, Guilarte TR. Molecular neurobiology of lead (Pb 2+): effects on synaptic function. Mol Neurobiol. 2010;42(3):151-160.
33. Flora GJ, Seth PK. Alterations in some membrane properties in rat brain following exposure to lead. Cytobios. 2000;103(403): 103-109.
34. Curer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning. Free Radic Biol Med. 2000;29(10):927-945.
35. He T, Hirsch HV, Ruden DM, et al. Chronic lead exposure alters presynaptic calcium regulation and synaptic facilitation in Drosophila larvae. Neurotoxicology. 2009;30(5):777-784.
36. White LD, Cory-Slechta DA, Gilbert ME. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol. 2007;225(1):1-27.
37. Wills NK, Ramanujam VM, Chang J, et al. Cadmium accumulation in the human retina: effects of age, gender, and cellular toxicity. Exp Eye Res. 2008;86(1):41-51.
38. Liu WD, Li TX. Determination of blood lead with graphite furnace atomic absorption spectrometry. Zhongguo Zhiye Yixue. 2007; 34(5):419-422.